[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

EA033170B1 - Method for gstm1 gene expression detection in samples of paraffin-fixed sections of mammary tumor tissue - Google Patents

Method for gstm1 gene expression detection in samples of paraffin-fixed sections of mammary tumor tissue

Info

Publication number
EA033170B1
EA033170B1 EA201500680A EA201500680A EA033170B1 EA 033170 B1 EA033170 B1 EA 033170B1 EA 201500680 A EA201500680 A EA 201500680A EA 201500680 A EA201500680 A EA 201500680A EA 033170 B1 EA033170 B1 EA 033170B1
Authority
EA
Eurasian Patent Office
Prior art keywords
cycles
gstm1
gene expression
fam
paraffin
Prior art date
Application number
EA201500680A
Other languages
Russian (ru)
Other versions
EA201500680A1 (en
Inventor
Юрий Евгеньевич Демидчик
Светлана Андреевна Костюк
Ирина Юрьевна Третьяк
Татьяна Владимировна Руденкова
Ольга Сергеевна Полуян
Original Assignee
Государственное Учреждение Образования "Белорусская Медицинская Академия Последипломного Образования" (Гуо "Белмапо")
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Государственное Учреждение Образования "Белорусская Медицинская Академия Последипломного Образования" (Гуо "Белмапо") filed Critical Государственное Учреждение Образования "Белорусская Медицинская Академия Последипломного Образования" (Гуо "Белмапо")
Priority to EA201500680A priority Critical patent/EA033170B1/en
Publication of EA201500680A1 publication Critical patent/EA201500680A1/en
Publication of EA033170B1 publication Critical patent/EA033170B1/en

Links

Landscapes

  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

The invention relates to medicine, in particular, to clinical laboratory diagnostics, and may be used for detecting the GSTM1 gene in samples of paraffin-fixed sections of mammary tumor tissue. The invention objective is to develop a method for detecting the GSTM1 gene expression in samples of paraffin-fixed sections of mammary tumor tissue, to provide the possibility of assessing the efficiency of the 2nd phase of xenobiotic biotransformation in the tumor cells (assessing the cells' ability of biochemically inactivating reactive xenobiotic metabolites). The objective is achieved as follows: human RNA is released from the paraffin-fixed sections of mammary tumor tissue, a reverse transcription reaction is conducted to obtain cDNA, which is then used for performing real-time TaqMan PCR with the use of matched pairs of primers and probes: for GSTM1 gene: forward-primer AAGTTGGCATGCCCATGATACTGG, reverse-primer CGTCCCCCATCGTGTACTTCTTTTC, TaqMan probe FAM-CCATCCGCCTGCTCCTGGAATA-BHQ1; for the reference gene HGUS: forward-primer CTCCAAGGAATTTTGCCGATT, reverse-primer GGCGTGAAGATCCGGTTTTTA, TaqMan probe JOE TGTTCAGTCACCGACAGTGCTG-BHQ2, the primers and the probes being introduced in a concentration of 3.2 pmol/μl, and then amplification is conducted according to the following programme: 1 cycle: 95°C - 5 min.; 50 cycles: 95°C - 20 s, 62°C - 20 s, 72°C - 15 s; 1 cycle: 72°C - 10 min, fluorescence detection is conducted at FAM and JOE channels; if the tested material has threshold cycle (Ct) values in the range of 0-20 cycles or 36-50 cycles for the JOE channel (reference gene HGUS), it is concluded that human cells are absent in the tested material and that GSTM1 gene expression cannot be assessed in the sample; if the tested material has Ct values in the range of 21-35 cycles for the JOE channel, it is concluded that human cells are present in the sample and then fluorescence data analysis is conducted for the channel FAM (gene GSTM1), if Ct values in the range of 21-35 cycles are determined for the FAM channel, a conclusion on the presence of GSTM1 gene expression is made, and if the tested material has Ct values in the range of 0-20 cycles or 36-50 cycles for the FAM channel, a conclusion is made on the absence of GSTM1 gene expression.
EA201500680A 2015-05-21 2015-05-21 Method for gstm1 gene expression detection in samples of paraffin-fixed sections of mammary tumor tissue EA033170B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EA201500680A EA033170B1 (en) 2015-05-21 2015-05-21 Method for gstm1 gene expression detection in samples of paraffin-fixed sections of mammary tumor tissue

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EA201500680A EA033170B1 (en) 2015-05-21 2015-05-21 Method for gstm1 gene expression detection in samples of paraffin-fixed sections of mammary tumor tissue

Publications (2)

Publication Number Publication Date
EA201500680A1 EA201500680A1 (en) 2016-11-30
EA033170B1 true EA033170B1 (en) 2019-09-30

Family

ID=57391626

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201500680A EA033170B1 (en) 2015-05-21 2015-05-21 Method for gstm1 gene expression detection in samples of paraffin-fixed sections of mammary tumor tissue

Country Status (1)

Country Link
EA (1) EA033170B1 (en)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003310284A (en) * 2002-01-30 2003-11-05 Sankyo Co Ltd Method for discriminating risk of liver disorder caused by administration of diabete mellitus-treating agent, and kit for the same purpose
EA006827B1 (en) * 1999-12-20 2006-04-28 Юниверсити Оф Саутерн Калифорния Method for isolation of rna from paraffin-embedded tissue specimens
CN101693920A (en) * 2009-10-10 2010-04-14 上海中优医药高科技有限公司 Glutathione-S-transferase genetype detection method
CN102586410A (en) * 2011-01-18 2012-07-18 苏州科贝生物技术有限公司 Reagent kit for quantitatively assessing long-term recurrence risks of breast cancer

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA006827B1 (en) * 1999-12-20 2006-04-28 Юниверсити Оф Саутерн Калифорния Method for isolation of rna from paraffin-embedded tissue specimens
JP2003310284A (en) * 2002-01-30 2003-11-05 Sankyo Co Ltd Method for discriminating risk of liver disorder caused by administration of diabete mellitus-treating agent, and kit for the same purpose
CN101693920A (en) * 2009-10-10 2010-04-14 上海中优医药高科技有限公司 Glutathione-S-transferase genetype detection method
CN102586410A (en) * 2011-01-18 2012-07-18 苏州科贝生物技术有限公司 Reagent kit for quantitatively assessing long-term recurrence risks of breast cancer

Also Published As

Publication number Publication date
EA201500680A1 (en) 2016-11-30

Similar Documents

Publication Publication Date Title
Blassl et al. Gene expression profiling of single circulating tumor cells in ovarian cancer–Establishment of a multi-marker gene panel
Nakanishi et al. Evaluation of forensic examination of extremely aged seminal stains
ATE534753T1 (en) COMPOSITIONS AND METHODS FOR IDENTIFYING A CARBAPENEMASE GENE
NZ598166A (en) Methods, primers, probes and kits useful for the detection of braf mutations
JP2019527544A (en) Molecular marker, reference gene, and application thereof, detection kit, and detection model construction method
EA201291001A1 (en) METHODS OF MEASUREMENT OF ENZYMATIVE ACTIVITY, USEFUL WHEN DETERMINING THE VIABILITY OF CELLS IN UNCLEANED SAMPLES
CN106978492A (en) A kind of multiple fluorescence PCR detection reagent box for being used to detect the gene expression dose of breast cancer 21
DE502008002136D1 (en) CONTROL GENES FOR THE NORMALIZATION OF GENE EXPRESSION ANALYSIS DATA
WO2011148269A3 (en) Differentiation of species within the mycobacterium tuberculosis complex
WO2016034715A3 (en) Method for predicting the development of colorectal cancer
WO2009061640A3 (en) Hepatitis b virus (hbv) specific oligonucleotide sequences
Niaz et al. Identification of valid reference genes for the normalization of RT-qPCR gene expression data in Alexandrium catenella under different nutritional conditions
JP6974182B2 (en) Health sign
CN107988329A (en) It is a kind of to be used to identify that multipotential stem cell is endogenous and detection primer group, kit and the detection method of external source versatility gene expression
SG10201906653YA (en) Single cell rna and mutational analysis pcr (scrm-pcr): a method for simultaneous analysis of dna and rna at the single-cell level
Kim et al. Comparison of droplet digital PCR and quantitative real-time PCR in mcrA-based methanogen community analysis
WO2011017013A3 (en) Enterococcus and fecal bacteroides for rapid water quality assessment
EA033170B1 (en) Method for gstm1 gene expression detection in samples of paraffin-fixed sections of mammary tumor tissue
CN104131113A (en) miRNA detection kit and application thereof
Sirker et al. Impact of using validated or standard reference genes for miRNA qPCR data normalization in cell type identification
CN102534023B (en) RCA (rolling circle amplification) rapid detection primer and kit for Yersinia enterocolitica
Eini et al. Chimeric external control to quantify cell free DNA in plasma samples by real time PCR
CN109837355B (en) Application of beckmannia syzigachne CYP704B1 gene
CN103757110B (en) A kind of vibrio cholerae analyzes parting kit
Sørensen et al. Common consensus LNA probe for quantitative PCR assays in cancer: vehicles for minimal residual disease detection in t (11; 14) and t (14; 18) positive malignant lymphomas

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG TJ TM RU